• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将扩展的三核苷酸重复序列引入人类基因组中,用于体外亨廷顿病建模。

Introducing an Expanded Trinucleotide Repeat Tract into the Human Genome for Huntington's Disease Modeling In Vitro.

机构信息

Federal Research Center Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Novosibirsk, Russia.

出版信息

Curr Protoc Hum Genet. 2020 Jun;106(1):e100. doi: 10.1002/cphg.100.

DOI:10.1002/cphg.100
PMID:32469433
Abstract

In neurodegeneration studies, researchers are faced with problems such as limited material availability and late disease manifestation. Cell models provide the opportunity to investigate molecular mechanisms of pathogenesis. Moreover, genome editing technologies enable generation of isogenic cell models of hereditary diseases. Our protocol outlines an approach for introducing an expanded CAG repeat tract into the first exon of the HTT gene, the Huntington's disease causing mutation. The protocol allows modeling the disease at various severity levels by introducing different numbers of CAG repeats. Furthermore, the protocol can be applicable for modeling other diseases caused by trinucleotide repeat expansion. It is important to note there are many difficulties with cloning repeated sequences and amplification of GC-rich regions. Here, we also propose troubleshooting options, which overcome these problems. The protocol is based on CRISPR/Cas9-mediated homologous recombination with a uniquely designed donor plasmid harboring an expanded CAG tract flanked with long homology arms. © 2020 Wiley Periodicals LLC. Basic Protocol 1: Design and assembling donor and CRISPR/Cas9-expressing plasmids Basic Protocol 2: Transfection of cells with plasmids and sorting GFP-positive cells Basic Protocol 3: PCR screening single-cell clones and validation of the mutant HTT expression.

摘要

在神经退行性疾病研究中,研究人员面临着材料有限和疾病晚期表现等问题。细胞模型为研究发病机制的分子机制提供了机会。此外,基因组编辑技术可用于产生遗传性疾病的同源细胞模型。本方案概述了一种将扩展的 CAG 重复序列引入 HTT 基因(亨廷顿病致病突变)第一外显子的方法。该方案可通过引入不同数量的 CAG 重复来模拟不同严重程度的疾病。此外,该方案可适用于模拟其他由三核苷酸重复扩展引起的疾病。需要注意的是,克隆重复序列和扩增 GC 丰富区域存在许多困难。在这里,我们还提出了故障排除选项,以克服这些问题。该方案基于 CRISPR/Cas9 介导的同源重组,使用独特设计的携带扩展 CAG 序列的供体质粒,两侧带有长同源臂。© 2020 Wiley Periodicals LLC. 基本方案 1:设计和组装供体和 CRISPR/Cas9 表达质粒 基本方案 2:用质粒转染细胞和分选 GFP 阳性细胞 基本方案 3:PCR 筛选单细胞克隆和验证突变 HTT 表达。

相似文献

1
Introducing an Expanded Trinucleotide Repeat Tract into the Human Genome for Huntington's Disease Modeling In Vitro.将扩展的三核苷酸重复序列引入人类基因组中,用于体外亨廷顿病建模。
Curr Protoc Hum Genet. 2020 Jun;106(1):e100. doi: 10.1002/cphg.100.
2
Generation of New Isogenic Models of Huntington's Disease Using CRISPR-Cas9 Technology.利用 CRISPR-Cas9 技术生成新的亨廷顿病同基因模型。
Int J Mol Sci. 2020 Mar 8;21(5):1854. doi: 10.3390/ijms21051854.
3
Introducing an expanded CAG tract into the huntingtin gene causes a wide spectrum of ultrastructural defects in cultured human cells.将扩展的 CAG 片段引入 huntingtin 基因会导致培养的人类细胞出现广泛的超微结构缺陷。
PLoS One. 2018 Oct 17;13(10):e0204735. doi: 10.1371/journal.pone.0204735. eCollection 2018.
4
Gene Therapy for Huntington's Disease Using Targeted Endonucleases.使用靶向核酸内切酶对亨廷顿舞蹈症进行基因治疗。
Methods Mol Biol. 2020;2056:269-284. doi: 10.1007/978-1-4939-9784-8_17.
5
Lack of RAN-mediated toxicity in Huntington's disease knock-in mice.亨廷顿病基因敲入小鼠中缺乏 RAN 介导的毒性。
Proc Natl Acad Sci U S A. 2020 Feb 25;117(8):4411-4417. doi: 10.1073/pnas.1919197117. Epub 2020 Feb 6.
6
Base editing strategies to convert CAG to CAA diminish the disease-causing mutation in Huntington's disease.将CAG转换为CAA的碱基编辑策略可减少亨廷顿舞蹈病中的致病突变。
Elife. 2024 Jun 13;12:RP89782. doi: 10.7554/eLife.89782.
7
Generation of Rhesus Macaque Embryos with Expanded CAG Trinucleotide Repeats in the Gene.基因中 CAG 三核苷酸重复序列扩展的恒河猴胚胎的产生。
Cells. 2024 May 13;13(10):829. doi: 10.3390/cells13100829.
8
CRISPR/Cas9 Editing of the Mutant Huntingtin Allele In Vitro and In Vivo.体外和体内对突变型亨廷顿蛋白等位基因进行CRISPR/Cas9编辑
Mol Ther. 2017 Jan 4;25(1):12-23. doi: 10.1016/j.ymthe.2016.11.010.
9
RNA toxicity induced by expanded CAG repeats in Huntington's disease.亨廷顿舞蹈病中由CAG重复序列扩增引起的RNA毒性。
Brain Pathol. 2016 Nov;26(6):779-786. doi: 10.1111/bpa.12427.
10
Lowering Mutant Huntingtin Using Tricyclo-DNA Antisense Oligonucleotides As a Therapeutic Approach for Huntington's Disease.使用三环 DNA 反义寡核苷酸降低突变型亨廷顿蛋白作为亨廷顿病的治疗方法。
Nucleic Acid Ther. 2019 Oct;29(5):256-265. doi: 10.1089/nat.2018.0775. Epub 2019 Jun 11.

引用本文的文献

1
Advances in Modeling Polyglutamine Diseases Using Genome Editing Tools.利用基因组编辑工具研究多聚谷氨酰胺疾病的进展。
Cells. 2022 Feb 2;11(3):517. doi: 10.3390/cells11030517.
2
Gene Therapy for Neurodegenerative Disease: Clinical Potential and Directions.神经退行性疾病的基因治疗:临床潜力与方向
Front Mol Neurosci. 2021 Jun 14;14:618171. doi: 10.3389/fnmol.2021.618171. eCollection 2021.
3
A Human Induced Pluripotent Stem Cell-Derived Isogenic Model of Huntington's Disease Based on Neuronal Cells Has Several Relevant Phenotypic Abnormalities.
一种基于神经元细胞的人类诱导多能干细胞衍生的亨廷顿舞蹈病同基因模型具有多种相关表型异常。
J Pers Med. 2020 Nov 9;10(4):215. doi: 10.3390/jpm10040215.